DAWN icon

Day One Biopharmaceuticals

87 hedge funds and large institutions have $1.04B invested in Day One Biopharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.91M
Puts
$2.78M
Net Calls
Net Calls Change

Top Sellers

1 -$8.95M
2 -$8.03M
3 -$6.44M
4
Millennium Management
Millennium Management
New York
-$2.81M
5
LCM
Laurion Capital Management
New York
-$1.37M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$173M
2
$161M
3
$126M
4
$122M
5
$62.9M
6
$49.2M
7
$47M
8
$44.1M
9
$36.5M
10
$35.1M
11
$33.9M
12
$33.2M
13
$21.3M
14
$13.2M
15
$9.95M
16
$8.98M
17
$7.92M
18
$6.42M
19
$3.89M
20
$3.52M
21
$3.41M
22
$2.74M
23
$2.69M
24
$2.61M
25
$2.48M